Skip to main content
Top
Published in: BMC Gastroenterology 1/2011

Open Access 01-12-2011 | Research article

A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis

Authors: Saskia Ditisheim, Emiliano Giostra, Pierre R Burkhard, Nicolas Goossens, Gilles Mentha, Antoine Hadengue, Laurent Spahr

Published in: BMC Gastroenterology | Issue 1/2011

Login to get access

Abstract

Background

Hepatic encephalopathy (HE) is a frequent and severe complication of cirrhosis. A single determination of ammonia in venous blood correlates poorly with neurological symptoms. Thus, a better biological marker is needed.

Aim

To make a diagnosis of HE, we explored the value of ammonia in capillary blood, an equivalent to arterial blood, measured at bedside following an oral glutamine challenge.

Methods

We included 57 patients (age 56 yrs; M/F: 37/20) with cirrhosis (alcoholic = 42; MELD score 13.8 [7-29], esophageal varices = 38) and previous episodes of HE (n = 19), but without neurological deficits at time of examination, and 13 healthy controls (age 54 yrs). After psychometric tests and capillary (ear lobe) blood ammonia measurements, 20 gr of glutamine was administered orally. Tests were repeated at 60 minutes (+ blood ammonia at 30'). Minimal HE was diagnosed if values were > 1.5 SD in at least 2 psychometric tests. Follow-up lasted 12 months.

Results

The test was well tolerated (nausea = 1; dizziness = 1). Patients showed higher values of capillary blood ammonia over time as compared to controls (0'-30'-60 minutes: 75, 117, 169 versus 52, 59, 78 umol/L, p < 0.05). At baseline, 25 patients (44%) had minimal HE, while 38 patients (67%) met the criteria for HE at 60 minutes (chi2: p < 0.01). For the diagnosis of minimal HE, using the ROC curve analysis, baseline capillary blood ammonia showed an AUC of 0.541 (CI: 0.38-0.7, p = 0.6), while at 60 minutes the AUC was 0.727 (CI: 0.58-0.87, p < 0.006). During follow-up, 18 patients (31%) developed clinical episodes of HE. At multivariate analysis, the MELD score (1.12 [1.018-1.236]), previous episodes of HE (3.2[1.069-9.58]), but not capillary blood ammonia, were independent predictors of event.

Conclusions

In patients with cirrhosis and normal neurological examination, bedside determination of ammonia in capillary blood following oral glutamine load is well tolerated and achieves a better diagnostic performance for minimal HE than basal capillary ammonia levels. However, capillary blood ammonia is a poor predictor of development of clinically overt HE.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bustamante J, et al: Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol. 1999, 30 (5): 890-5. 10.1016/S0168-8278(99)80144-5.CrossRefPubMed Bustamante J, et al: Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol. 1999, 30 (5): 890-5. 10.1016/S0168-8278(99)80144-5.CrossRefPubMed
2.
go back to reference Stewart CA, et al: Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl. 2007, 13 (10): 1366-71. 10.1002/lt.21129.CrossRefPubMed Stewart CA, et al: Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. Liver Transpl. 2007, 13 (10): 1366-71. 10.1002/lt.21129.CrossRefPubMed
3.
go back to reference Ortiz M, Jacas C, Cordoba J: Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol. 2005, 42 Suppl (1): S45-53.CrossRefPubMed Ortiz M, Jacas C, Cordoba J: Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol. 2005, 42 Suppl (1): S45-53.CrossRefPubMed
4.
go back to reference Romero-Gomez M, et al: Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001, 96 (9): 2718-23.CrossRefPubMed Romero-Gomez M, et al: Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol. 2001, 96 (9): 2718-23.CrossRefPubMed
5.
go back to reference Bernardi M, Gitto S, Biselli M: The MELD score in patients awaiting liver transplant: Strengths and weaknesses. J Hepatol. 2011, 54 (6): 1297-306. 10.1016/j.jhep.2010.11.008.CrossRefPubMed Bernardi M, Gitto S, Biselli M: The MELD score in patients awaiting liver transplant: Strengths and weaknesses. J Hepatol. 2011, 54 (6): 1297-306. 10.1016/j.jhep.2010.11.008.CrossRefPubMed
6.
go back to reference Butterworth RF: Complications of cirrhosis III. Hepatic encephalopathy. Journal of hepatology. 2000, 32 (1 Suppl): 171-80.CrossRefPubMed Butterworth RF: Complications of cirrhosis III. Hepatic encephalopathy. Journal of hepatology. 2000, 32 (1 Suppl): 171-80.CrossRefPubMed
7.
go back to reference Tarantino G, et al: Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins. BMC gastroenterology. 2009, 9: 21-10.1186/1471-230X-9-21.CrossRefPubMedPubMedCentral Tarantino G, et al: Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins. BMC gastroenterology. 2009, 9: 21-10.1186/1471-230X-9-21.CrossRefPubMedPubMedCentral
8.
go back to reference Nicolao F, et al: Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy. J Hepatol. 2003, 38 (4): 441-6. 10.1016/S0168-8278(02)00436-1.CrossRefPubMed Nicolao F, et al: Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy. J Hepatol. 2003, 38 (4): 441-6. 10.1016/S0168-8278(02)00436-1.CrossRefPubMed
9.
go back to reference Romero-Gomez M, et al: Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy. J Hepatol. 2004, 41 (1): 49-54. 10.1016/j.jhep.2004.03.021.CrossRefPubMed Romero-Gomez M, et al: Intestinal glutaminase activity is increased in liver cirrhosis and correlates with minimal hepatic encephalopathy. J Hepatol. 2004, 41 (1): 49-54. 10.1016/j.jhep.2004.03.021.CrossRefPubMed
10.
go back to reference Lockwood AH: Blood ammonia levels and hepatic encephalopathy. Metab Brain Dis. 2004, 19 (3-4): 345-9.CrossRefPubMed Lockwood AH: Blood ammonia levels and hepatic encephalopathy. Metab Brain Dis. 2004, 19 (3-4): 345-9.CrossRefPubMed
11.
go back to reference Butterworth RF: Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metabolic brain disease. 2002, 17 (4): 221-7. 10.1023/A:1021989230535.CrossRefPubMed Butterworth RF: Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metabolic brain disease. 2002, 17 (4): 221-7. 10.1023/A:1021989230535.CrossRefPubMed
12.
go back to reference Das A, et al: Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. Journal of gastroenterology and hepatology. 2001, 16 (5): 531-5. 10.1046/j.1440-1746.2001.02487.x.CrossRefPubMed Das A, et al: Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. Journal of gastroenterology and hepatology. 2001, 16 (5): 531-5. 10.1046/j.1440-1746.2001.02487.x.CrossRefPubMed
13.
go back to reference Spahr L, et al: Histamine H1 blocker hydroxyzine improves sleep in patients with cirrhosis and minimal hepatic encephalopathy: a randomized controlled pilot trial. The American journal of gastroenterology. 2007, 102 (4): 744-53. 10.1111/j.1572-0241.2006.01028.x.CrossRefPubMed Spahr L, et al: Histamine H1 blocker hydroxyzine improves sleep in patients with cirrhosis and minimal hepatic encephalopathy: a randomized controlled pilot trial. The American journal of gastroenterology. 2007, 102 (4): 744-53. 10.1111/j.1572-0241.2006.01028.x.CrossRefPubMed
14.
go back to reference Teasdale G, Jennett B: Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974, 2 (7872): 81-4.CrossRefPubMed Teasdale G, Jennett B: Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974, 2 (7872): 81-4.CrossRefPubMed
15.
go back to reference Cordoba J: New assessment of hepatic encephalopathy. Journal of hepatology. 2011, 54 (5): 1030-40. 10.1016/j.jhep.2010.11.015.CrossRefPubMed Cordoba J: New assessment of hepatic encephalopathy. Journal of hepatology. 2011, 54 (5): 1030-40. 10.1016/j.jhep.2010.11.015.CrossRefPubMed
16.
go back to reference Snady H, Lieber CS: Venous, arterial, and arterialized-venous blood ammonia levels and their relationship to hepatic encephalopathy after propranolol. The American journal of gastroenterology. 1988, 83 (3): 249-55.PubMed Snady H, Lieber CS: Venous, arterial, and arterialized-venous blood ammonia levels and their relationship to hepatic encephalopathy after propranolol. The American journal of gastroenterology. 1988, 83 (3): 249-55.PubMed
17.
go back to reference Kramer L, et al: Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology. 2000, 31 (1): 30-4. 10.1002/hep.510310107.CrossRefPubMed Kramer L, et al: Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology. 2000, 31 (1): 30-4. 10.1002/hep.510310107.CrossRefPubMed
18.
go back to reference Ong JP, et al: Correlation between ammonia levels and the severity of hepatic encephalopathy. The American journal of medicine. 2003, 114 (3): 188-93. 10.1016/S0002-9343(02)01477-8.CrossRefPubMed Ong JP, et al: Correlation between ammonia levels and the severity of hepatic encephalopathy. The American journal of medicine. 2003, 114 (3): 188-93. 10.1016/S0002-9343(02)01477-8.CrossRefPubMed
19.
go back to reference Romero-Gomez M, et al: Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy. J Hepatol. 2002, 37 (6): 781-7. 10.1016/S0168-8278(02)00330-6.CrossRefPubMed Romero-Gomez M, et al: Altered response to oral glutamine challenge as prognostic factor for overt episodes in patients with minimal hepatic encephalopathy. J Hepatol. 2002, 37 (6): 781-7. 10.1016/S0168-8278(02)00330-6.CrossRefPubMed
20.
go back to reference Spahr L, et al: Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis. Gastroenterology. 2000, 119 (3): 774-81. 10.1053/gast.2000.17857.CrossRefPubMed Spahr L, et al: Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis. Gastroenterology. 2000, 119 (3): 774-81. 10.1053/gast.2000.17857.CrossRefPubMed
21.
go back to reference Kircheis G, et al: Assessment of low-grade hepatic encephalopathy: a critical analysis. Journal of hepatology. 2007, 47 (5): 642-50. 10.1016/j.jhep.2007.05.019.CrossRefPubMed Kircheis G, et al: Assessment of low-grade hepatic encephalopathy: a critical analysis. Journal of hepatology. 2007, 47 (5): 642-50. 10.1016/j.jhep.2007.05.019.CrossRefPubMed
22.
go back to reference Oppong KN, et al: Oral glutamine challenge in cirrhotics pre- and post-liver transplantation: a psychometric and analyzed EEG study. Hepatology. 1997, 26 (4): 870-6. 10.1002/hep.510260411.CrossRefPubMed Oppong KN, et al: Oral glutamine challenge in cirrhotics pre- and post-liver transplantation: a psychometric and analyzed EEG study. Hepatology. 1997, 26 (4): 870-6. 10.1002/hep.510260411.CrossRefPubMed
23.
go back to reference Huizenga JR, Gips CH, Krom RA: Arterial blood ammonia during orthotopic liver transplantation as an indicator of waste elimination by the new liver. Clinica chimica acta; international journal of clinical chemistry. 1995, 239 (1): 103-6. 10.1016/0009-8981(95)06099-Y.CrossRefPubMed Huizenga JR, Gips CH, Krom RA: Arterial blood ammonia during orthotopic liver transplantation as an indicator of waste elimination by the new liver. Clinica chimica acta; international journal of clinical chemistry. 1995, 239 (1): 103-6. 10.1016/0009-8981(95)06099-Y.CrossRefPubMed
24.
go back to reference Huizenga JR, van Dam GM, Gips CH: Arterial ammonia with Blood Ammonia Checker II and with indophenol reaction to assess presence of hepatic encephalopathy. Clinica chimica acta; international journal of clinical chemistry. 1996, 252 (1): 73-82. 10.1016/0009-8981(96)06324-3.CrossRefPubMed Huizenga JR, van Dam GM, Gips CH: Arterial ammonia with Blood Ammonia Checker II and with indophenol reaction to assess presence of hepatic encephalopathy. Clinica chimica acta; international journal of clinical chemistry. 1996, 252 (1): 73-82. 10.1016/0009-8981(96)06324-3.CrossRefPubMed
25.
go back to reference Bajaj JS, et al: Testing for minimal hepatic encephalopathy in the United States: An AASLD survey. Hepatology. 2007, 45 (3): 833-4. 10.1002/hep.21515.CrossRefPubMed Bajaj JS, et al: Testing for minimal hepatic encephalopathy in the United States: An AASLD survey. Hepatology. 2007, 45 (3): 833-4. 10.1002/hep.21515.CrossRefPubMed
26.
go back to reference Romero-Gomez M, Grande L, Camacho I: Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. Hepatology. 2004, 39 (4): 939-43. 10.1002/hep.20152.CrossRefPubMed Romero-Gomez M, Grande L, Camacho I: Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. Hepatology. 2004, 39 (4): 939-43. 10.1002/hep.20152.CrossRefPubMed
27.
go back to reference Riggio O, et al: Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. The American journal of gastroenterology. 2008, 103 (11): 2738-46. 10.1111/j.1572-0241.2008.02102.x.CrossRefPubMed Riggio O, et al: Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. The American journal of gastroenterology. 2008, 103 (11): 2738-46. 10.1111/j.1572-0241.2008.02102.x.CrossRefPubMed
28.
go back to reference Romero-Gomez M, et al: Gut ammonia production and its modulation. Metab Brain Dis. 2009, 24 (1): 147-57. 10.1007/s11011-008-9124-3.CrossRefPubMed Romero-Gomez M, et al: Gut ammonia production and its modulation. Metab Brain Dis. 2009, 24 (1): 147-57. 10.1007/s11011-008-9124-3.CrossRefPubMed
29.
go back to reference Ortiz M, et al: Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts. J Hepatol. 2004, 40 (3): 552-7. 10.1016/j.jhep.2004.01.013.CrossRefPubMed Ortiz M, et al: Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts. J Hepatol. 2004, 40 (3): 552-7. 10.1016/j.jhep.2004.01.013.CrossRefPubMed
30.
go back to reference Balata S, et al: Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. Hepatology. 2003, 37 (4): 931-9. 10.1053/jhep.2003.50156.CrossRefPubMed Balata S, et al: Induced hyperammonemia alters neuropsychology, brain MR spectroscopy and magnetization transfer in cirrhosis. Hepatology. 2003, 37 (4): 931-9. 10.1053/jhep.2003.50156.CrossRefPubMed
31.
go back to reference Masini A, et al: Effect of blood ammonia elevation following oral glutamine load on the psychometric performance of cirrhotic patients. Metabolic brain disease. 2003, 18 (1): 27-35. 10.1023/A:1021926601907.CrossRefPubMed Masini A, et al: Effect of blood ammonia elevation following oral glutamine load on the psychometric performance of cirrhotic patients. Metabolic brain disease. 2003, 18 (1): 27-35. 10.1023/A:1021926601907.CrossRefPubMed
32.
go back to reference Douglass A, Al Mardini H, Record C: Amino acid challenge in patients with cirrhosis: a model for the assessment of treatments for hepatic encephalopathy. J Hepatol. 2001, 34 (5): 658-64. 10.1016/S0168-8278(01)00004-6.CrossRefPubMed Douglass A, Al Mardini H, Record C: Amino acid challenge in patients with cirrhosis: a model for the assessment of treatments for hepatic encephalopathy. J Hepatol. 2001, 34 (5): 658-64. 10.1016/S0168-8278(01)00004-6.CrossRefPubMed
33.
go back to reference Masini A, et al: Effect of lactitol on blood ammonia response to oral glutamine challenge in cirrhotic patients: evidence for an effect of nonabsorbable disaccharides on small intestine ammonia generation. Am J Gastroenterol. 1999, 94 (11): 3323-7. 10.1111/j.1572-0241.1999.01546.x.CrossRefPubMed Masini A, et al: Effect of lactitol on blood ammonia response to oral glutamine challenge in cirrhotic patients: evidence for an effect of nonabsorbable disaccharides on small intestine ammonia generation. Am J Gastroenterol. 1999, 94 (11): 3323-7. 10.1111/j.1572-0241.1999.01546.x.CrossRefPubMed
34.
go back to reference Rees CJ, et al: Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial. Gut. 2000, 47 (4): 571-4. 10.1136/gut.47.4.571.CrossRefPubMedPubMedCentral Rees CJ, et al: Effect of L-ornithine-L-aspartate on patients with and without TIPS undergoing glutamine challenge: a double blind, placebo controlled trial. Gut. 2000, 47 (4): 571-4. 10.1136/gut.47.4.571.CrossRefPubMedPubMedCentral
35.
go back to reference Guevara M, et al: Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. The American journal of gastroenterology. 2009, 104 (6): 1382-9. 10.1038/ajg.2009.293.CrossRefPubMed Guevara M, et al: Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. The American journal of gastroenterology. 2009, 104 (6): 1382-9. 10.1038/ajg.2009.293.CrossRefPubMed
36.
go back to reference Schulz GJ, Campos AC, Coelho JC: The role of nutrition in hepatic encephalopathy. Current opinion in clinical nutrition and metabolic care. 2008, 11 (3): 275-80. 10.1097/MCO.0b013e3282f9e870.CrossRefPubMed Schulz GJ, Campos AC, Coelho JC: The role of nutrition in hepatic encephalopathy. Current opinion in clinical nutrition and metabolic care. 2008, 11 (3): 275-80. 10.1097/MCO.0b013e3282f9e870.CrossRefPubMed
37.
go back to reference Citro V, et al: Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infection. Journal of gastroenterology. 2007, 42 (1): 79-82. 10.1007/s00535-006-1978-8.CrossRefPubMed Citro V, et al: Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infection. Journal of gastroenterology. 2007, 42 (1): 79-82. 10.1007/s00535-006-1978-8.CrossRefPubMed
38.
go back to reference Shawcross DL, et al: Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. Journal of hepatology. 2011, 54 (4): 640-9. 10.1016/j.jhep.2010.07.045.CrossRefPubMed Shawcross DL, et al: Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. Journal of hepatology. 2011, 54 (4): 640-9. 10.1016/j.jhep.2010.07.045.CrossRefPubMed
Metadata
Title
A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis
Authors
Saskia Ditisheim
Emiliano Giostra
Pierre R Burkhard
Nicolas Goossens
Gilles Mentha
Antoine Hadengue
Laurent Spahr
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2011
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-11-134

Other articles of this Issue 1/2011

BMC Gastroenterology 1/2011 Go to the issue